Precision NanoSystems

Precision NanoSystems, Inccreates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines, and in medical research. PNI’s proprietary NanoAssemblr platform enables the rapid, reproducible, and scalable manufacture of next-generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies and builds strategic collaborations to revolutionize healthcare through nanotechnology.

Management

James Taylor

CEO

Euan Ramsay

COO

Connect

News

Precision NanoSystems Launches the NanoAssemblr Blaze

Precision NanoSystems to Advance Large-Scale Production of Nanoparticles with its NanoAssemblr Blaze System

Read more

Precision NanoSystems Launches the NanoAssemblr Spark

Precision NanoSystems launches innovative product to support mRNA and CRISPR/Cas9 therapeutic development

Read more

Vancouver-based nanomedicine startup targets genetic solution to diseases

Vancouver-based biotech firm Precision NanoSystems Inc. (PNI) has created a tabletop device that produces “self-assembling” molecules that carry drugs and gene therapies directly…

Read more

Precision NanoSystems Raises $13.4M in Series A Financing

VANCOUVER, British Columbia, Sept. 29, 2015 /PRNewswire/ — Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing…

Read more

Precision NanoSystems Raises $13.4M in Series A Financing

Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing.

Read more